{"id":8247,"date":"2025-05-02T17:49:32","date_gmt":"2025-05-02T09:49:32","guid":{"rendered":"https:\/\/regask.com\/?page_id=8247"},"modified":"2025-05-05T10:15:36","modified_gmt":"2025-05-05T02:15:36","slug":"rappt-euro-konvergenz-2025","status":"publish","type":"page","link":"https:\/\/regask.com\/de\/raps-euro-convergence-2025\/","title":{"rendered":"RAPS Euro-Konvergenz 2025"},"content":{"rendered":"<div id=\"gap-1978237067\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1978237067 {\n  padding-top: 90px;\n}\n<\/style>\n\t<\/div>\n\t\n\n\t<section class=\"section\" id=\"section_918175195\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/06\/Careers-header-bg.svg\" class=\"bg attachment-medium_large size-medium_large\" alt=\"Karriere Header Bg\" \/>\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row row-large align-middle\"  id=\"row-232914484\">\n\n\t<div id=\"col-1778524216\" class=\"col medium-5 small-12 large-5\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div class=\"img has-hover no-margin x md-x lg-x y md-y lg-y\" id=\"image_2055004019\">\n\t\t\t\t\t\t\t\t<div class=\"img-inner dark\" >\n\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"720\" height=\"720\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS.png\" class=\"attachment-medium_large size-medium_large\" alt=\"Regask Raps\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS.png 720w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS-330x330.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS-12x12.png 12w\" sizes=\"auto, (max-width: 720px) 100vw, 720px\" \/>\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n<style>\n#image_2055004019 {\n  width: 90%;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1778524216 > .col-inner {\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1827542803\" class=\"col medium-6 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h5><span style=\"font-size: 95%;\" data-text-color=\"secondary\">REGASK-SPONSOREN<\/span><\/h5>\n<h1><span style=\"font-size: 90%;\">RAPS Euro-Konvergenz 2025<\/span><\/h1>\n<div class=\"is-divider divider clearfix\" style=\"max-width:40px;background-color:rgb(145, 138, 215);\"><\/div>\n\t<div id=\"text-3036762963\" class=\"text\">\n\t\t\n<p data-line-height=\"s\"><span data-text-color=\"primary\"><strong>13.-16. MAI 2025 | BR\u00dcSSEL, BELGIEN<\/strong><\/span><\/p>\n<p data-line-height=\"s\"><span data-text-color=\"primary\"><strong>Square Brussels Convention Centre, Stand Nr. 3<\/strong><\/span><\/p>\n\t\t\n<style>\n#text-3036762963 {\n  text-align: left;\n  color: rgb(227, 227, 227);\n}\n#text-3036762963 > * {\n  color: rgb(227, 227, 227);\n}\n<\/style>\n\t<\/div>\n\t\n<a href=\"https:\/\/regask.com\/de\/rappt-euro-konvergenz-2025\/#register20\" class=\"button secondary\" >\n\t\t<span>Treffen Sie uns auf der RAPS Euro Convergence 2025!<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_918175195 {\n  padding-top: 30px;\n  padding-bottom: 30px;\n}\n@media (min-width:550px) {\n  #section_918175195 {\n    padding-top: 60px;\n    padding-bottom: 60px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\n<span class=\"scroll-to\" data-label=\"Scroll to: #register20\" data-bullet=\"false\" data-link=\"#register20\" data-title=\"Register\"><a name=\"register20\"><\/a><\/span>\n<div class=\"row row-collapse row-full-width\"  id=\"row-2062233092\">\n\n\t<div id=\"col-495945107\" class=\"col medium-12 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n\n\t<section class=\"section dark\" id=\"section_1431751630\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-center\"  id=\"row-603438215\">\n\n\t<div id=\"col-238824776\" class=\"col medium-8 small-12 large-8\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"text-2476236412\" class=\"text\">\n\t\t\n<h3>Lernen Sie unser Team kennen<\/h3>\n\t\t\n<style>\n#text-2476236412 {\n  font-size: 1.5rem;\n  text-align: left;\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"gap-1120144896\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1120144896 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-3687648758\" class=\"text\">\n\t\t\n<p class=\"p1\"><span style=\"font-size: 90%;\">Verbinden<span class=\"s1\">, <span class=\"s1\"><b>Yasmine Fathallah<\/b><\/span>, Und <span class=\"s1\"><b>Ilkka Howard<\/b><\/span> am Stand von RegASK, um zu erfahren, wie unsere KI-gesteuerte regulatorische Intelligenz Compliance-Strategien ver\u00e4ndert.<\/span><\/span><\/p>\n<p><span style=\"font-size: 90%;\">Erfahren Sie mit ihnen mehr \u00fcber \u2013 <\/span><\/p>\n<ul>\n<li><span style=\"font-size: 90%;\">Die bahnbrechende Rolle der KI bei der Revolutionierung der regulatorischen Intelligenz<\/span><\/li>\n<li><span style=\"font-size: 90%;\">Wie die Spitzentechnologie von RegASK regulatorische Arbeitsabl\u00e4ufe optimiert<\/span><\/li>\n<li><span style=\"font-size: 90%;\">Wie unsere KI-gesteuerten L\u00f6sungen Ihrem Unternehmen dabei helfen k\u00f6nnen, den sich entwickelnden globalen Vorschriften immer einen Schritt voraus zu sein.<\/span><\/li>\n<\/ul>\n\t\t\n<style>\n#text-3687648758 {\n  text-align: left;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-238824776 > .col-inner {\n  margin: 0px 40px 0px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row align-center\"  id=\"row-860125909\">\n\n\t<div id=\"col-1572228209\" class=\"col medium-9 small-12 large-9\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div class=\"box has-hover   has-hover box-default box-text-bottom\" >\n\n\t\t<div class=\"box-image\" >\n\t\t\t\t\t\t<div class=\"\" >\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"979\" height=\"401\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/05\/RAPS-Euro-Convergence-attendees-v2.png\" class=\"attachment- size-\" alt=\"Raps Euro Convergence Teilnehmer V2\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/05\/RAPS-Euro-Convergence-attendees-v2.png 979w, https:\/\/regask.com\/wp-content\/uploads\/2025\/05\/RAPS-Euro-Convergence-attendees-v2-330x135.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/05\/RAPS-Euro-Convergence-attendees-v2-18x7.png 18w\" sizes=\"auto, (max-width: 979px) 100vw, 979px\" \/>\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\t<div class=\"box-text text-center is-small\" >\n\t\t\t<div class=\"box-text-inner\">\n\t\t\t\t\n\t<div id=\"gap-384879827\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-384879827 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<div class=\"row align-center\"  id=\"row-838460925\">\n\n\t<div id=\"col-1841528661\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<p><span style=\"font-size: 100%;\"><strong>Yasmine Fathallah<\/strong><\/span><\/p>\n<p>Client Solution Manager<\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-1771668162\" class=\"col medium-1 small-12 large-1\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-732848880\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<p><span style=\"font-size: 100%;\"><strong>Ilkka Howard<\/strong><\/span><\/p>\n<p>Account-Direktor f\u00fcr Gesch\u00e4ftsentwicklung<\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n\t<div id=\"gap-565221611\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-565221611 {\n  padding-top: 0px;\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1431751630 {\n  padding-top: 70px;\n  padding-bottom: 70px;\n  min-height: 900px;\n  background-color: rgb(10, 35, 66);\n}\n@media (min-width:550px) {\n  #section_1431751630 {\n    padding-top: 20px;\n    padding-bottom: 20px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-520710623\" class=\"col medium-12 small-12 large-6\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n\n\t<section class=\"section dark\" id=\"section_863472297\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-center\"  id=\"row-1862740394\">\n\n\t<div id=\"col-1581647193\" class=\"col medium-10 small-12 large-10\"  data-animate=\"fadeInRight\">\n\t\t\t\t<div class=\"col-inner text-center box-shadow-2\" style=\"background-color:rgb(255, 255, 255);\" >\n\t\t\t\n\t\t\t\n\n<p><script charset=\"utf-8\" type=\"text\/javascript\" src=\"\/\/js.hsforms.net\/forms\/embed\/v2.js\"><\/script><br \/>\n<script>\n  hbspt.forms.create({\n    portalId: \"20908020\",\n    formId: \"cf433518-1c2a-4d74-815a-a83d4de7893e\",\n    region: \"na1\"\n  });\n<\/script><br \/>\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1581647193 > .col-inner {\n  padding: 30px 30px 30px 30px;\n  border-radius: 16px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_863472297 {\n  padding-top: 70px;\n  padding-bottom: 70px;\n  min-height: 900px;\n  background-color: rgb(251, 250, 254);\n}\n@media (min-width:550px) {\n  #section_863472297 {\n    padding-top: 0px;\n    padding-bottom: 0px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\n\t<section class=\"section\" id=\"section_1884552078\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t<img decoding=\"async\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/bg-flip-card-1.svg\" class=\"bg attachment- size-\" alt=\"Bg Flip-Karte 1\" \/>\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row\"  id=\"row-1637029543\">\n\n\t<div id=\"col-1088957434\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-724813980\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-724813980 {\n  padding-top: 40px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>RAPS Euro-Konvergenz 2025<\/h2>\n\t<div id=\"text-3418441894\" class=\"text\">\n\t\t\n<p>RAPS Euro Convergence ist die umfassendste Konferenz f\u00fcr regulatorische Angelegenheiten in Europa. Der Schwerpunkt liegt auf den neuesten Themen und Entwicklungen bei Gesundheitsprodukten in Europa und dar\u00fcber hinaus \u2013 mit Sitzungen zu Medizinprodukten, IVDs, Arzneimitteln, Kombinationsprodukten, regulatorischem Gesch\u00e4ft, KI, Software und Cybersicherheit.<\/p>\n<p>RAPS Euro Convergence bringt Fachleute f\u00fcr regulatorische Angelegenheiten und Industriepartner zusammen, um gemeinsam L\u00f6sungen zur Verbesserung und Weiterentwicklung der Gesundheitsversorgung in Europa zu entwickeln.<\/p>\n<h3><span style=\"font-size: 85%;\">Gr\u00fcnde f\u00fcr die Teilnahme<\/span><\/h3>\n<ul>\n<li>Greifen Sie auf kuratierte Inhalte von hochrangigen Regulierungsexperten der EU und namhaften Gesundheitsbeh\u00f6rden zu.<\/li>\n<li>Informieren Sie sich \u00fcber die neuesten Innovationen bei L\u00f6sungsanbietern aus der EU und aller Welt.<\/li>\n<li>Erleben Sie umfassende Einblicke, Perspektiven und den Austausch mit globalen F\u00fchrungskr\u00e4ften, um umsetzbare, intelligente Roadmaps f\u00fcr Ihr Unternehmen zu beschleunigen.<\/li>\n<\/ul>\n<h3><span style=\"font-size: 85%;\">RAPS Euro Convergence 2025 Programm<\/span><\/h3>\n<p>RAPS Euro Convergence vermittelt grundlegendes Wissen in den Bereichen Medizinprodukte, IVD und Pharma, das Sie auf die erfolgreiche Navigation durch die regulatorische Landschaft der EU vorbereitet.<\/p>\n<h3><span style=\"font-size: 85%;\">Transformation des europ\u00e4ischen Regulierungsumfelds durch kollaborative Innovation<\/span><\/h3>\n<p>Die europ\u00e4ische Regulatory-Affairs-Community hat innerhalb der europ\u00e4ischen Gesundheitsbranche gro\u00dfe Fortschritte gemacht. Wie kann Europa angesichts dieser Fortschritte seine globale Position und Wettbewerbsf\u00e4higkeit in den kommenden Jahren behaupten? Die Regulatory-Affairs-Community trifft sich vom 13. bis 16. Mai in Br\u00fcssel, Belgien, zu intensiven Weiterbildungs- und Diskussionsveranstaltungen mit Schwerpunkt auf Innovation, Nachhaltigkeit, Resilienz und dynamischer Transformation, um die europ\u00e4ische Region als f\u00fchrende Region in der Gesundheitsregulierung zu positionieren.<br \/>\n\t\t\n<style>\n#text-3418441894 {\n  text-align: left;\n  color: rgb(17, 59, 111);\n}\n#text-3418441894 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n<a href=\"https:\/\/regask.com\/de\/raps-konferenz-2025\/#register20\" class=\"button secondary\" >\n\t\t<span>Treffen Sie uns auf der RAPS Euro Convergence 2025!<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1884552078 {\n  padding-top: 60px;\n  padding-bottom: 60px;\n  background-color: rgb(255, 255, 255);\n}\n<\/style>\n\t<\/section>\n\t\n\n\t<section class=\"section\" id=\"section_983004450\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-equal align-center\"  id=\"row-1761353436\">\n\n\t<div id=\"col-1334129588\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Unsere L\u00f6sung<\/h2>\n<p>RegASK nutzt fortschrittliche KI und maschinelles Lernen, um Unternehmen in stark regulierten Branchen dabei zu unterst\u00fctzen, ihre Prozesse zur Einhaltung gesetzlicher Vorschriften zu optimieren und stets einen Schritt voraus zu sein. Unsere innovative L\u00f6sung automatisiert die regulatorische Forschung, liefert wichtige Erkenntnisse und bef\u00e4higt Regulatory Affairs-Teams, strategische Partner f\u00fcr das Unternehmenswachstum zu werden.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1334129588 > .col-inner {\n  padding: 0px 0px 0px 0px;\n}\n@media (min-width:550px) {\n  #col-1334129588 > .col-inner {\n    padding: 0px 50px 0px 50px;\n  }\n}\n@media (min-width:850px) {\n  #col-1334129588 > .col-inner {\n    padding: 0px 170px 0px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1172457471\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/RegGenius-Product-Icon-2.svg\" class=\"attachment-medium size-medium\" alt=\"Reggenius Produktsymbol (2)\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-2032209831\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">RegGenius<\/h4>\n\t\t\n<style>\n#text-2032209831 {\n  color: rgb(10, 35, 66);\n}\n#text-2032209831 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-4150466677\" class=\"text\">\n\t\t\n<p>Nutzen Sie die Leistungsf\u00e4higkeit der KI, um sich bei der Einhaltung gesetzlicher Vorschriften einen Wettbewerbsvorteil zu verschaffen.<br \/>\n\t\t\n<style>\n#text-4150466677 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-4150466677 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1172457471 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 0px 0px;\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1184268007\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/Alerts-icon.svg\" class=\"attachment-medium size-medium\" alt=\"Warnsymbol\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-4036436147\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">RegAlert<\/h4>\n\t\t\n<style>\n#text-4036436147 {\n  color: rgb(10, 35, 66);\n}\n#text-4036436147 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-1606170725\" class=\"text\">\n\t\t\n<p>Keine \u00dcberraschungen durch automatisierte Regulierungs\u00fcberwachung.<br \/>\n\t\t\n<style>\n#text-1606170725 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-1606170725 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1184268007 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 0px 0px;\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1735615349\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/Data-Driven-Excellence-icon.svg\" class=\"attachment-medium size-medium\" alt=\"Symbol f\u00fcr datengesteuerte Exzellenz\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-1700257285\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">RegInsights<\/h4>\n\t\t\n<style>\n#text-1700257285 {\n  color: rgb(10, 35, 66);\n}\n#text-1700257285 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-2774092878\" class=\"text\">\n\t\t\n<p>Erkennen Sie Trends, antizipieren Sie Risiken und entwickeln Sie bessere Strategien.<br \/>\n\t\t\n<style>\n#text-2774092878 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-2774092878 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1735615349 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 0px 0px;\n  border-radius: 30px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1706342723\" class=\"col medium-5 small-12 large-3\"  data-animate=\"bounceIn\">\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:rgb(255,255,255);\" >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-color:rgb(229, 232, 251);border-radius:30px;border-width:2px 2px 2px 2px;\">\n\t<\/div>\n\t\t\t\n\n\t\t<div class=\"icon-box featured-box icon-box-top text-left\"  >\n\t\t\t\t\t<div class=\"icon-box-img\" style=\"width: 64px\">\n\t\t\t\t<div class=\"icon\">\n\t\t\t\t\t<div class=\"icon-inner\" >\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/07\/AskRegASK-Product-Icon.svg\" class=\"attachment-medium size-medium\" alt=\"AskRegASK Produktsymbol\" \/>\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t<div class=\"icon-box-text last-reset\">\n\t\t\t\t\t\t\t\t\t\n\t<div id=\"text-1168696117\" class=\"text\">\n\t\t\n<h4 style=\"margin: 10px 0;\">Ask RegASK<\/h4>\n\t\t\n<style>\n#text-1168696117 {\n  color: rgb(10, 35, 66);\n}\n#text-1168696117 > * {\n  color: rgb(10, 35, 66);\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"text-1518295465\" class=\"text\">\n\t\t\n<p>Zugriff auf unsere Community aus Regulierungsfachexperten.<br \/>\n\t\t\n<style>\n#text-1518295465 {\n  font-size: 0.87rem;\n  color: rgb(17, 59, 111);\n}\n#text-1518295465 > * {\n  color: rgb(17, 59, 111);\n}\n<\/style>\n\t<\/div>\n\t\n\t\t<\/div>\n\t<\/div>\n\t\n\t\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1706342723 > .col-inner {\n  padding: 30px 20px 30px 20px;\n  margin: 0px 0px 30px 0px;\n  border-radius: 30px;\n}\n@media (min-width:550px) {\n  #col-1706342723 > .col-inner {\n    margin: 0px 0px 0px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_983004450 {\n  padding-top: 0px;\n  padding-bottom: 0px;\n  background-color: rgb(250, 250, 250);\n}\n@media (min-width:550px) {\n  #section_983004450 {\n    padding-top: 60px;\n    padding-bottom: 60px;\n  }\n}\n<\/style>\n\t<\/section>\n\t\n\n\t<section class=\"section\" id=\"section_113422710\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n<div class=\"row align-center\"  id=\"row-1290665117\">\n\n\t<div id=\"col-161652966\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n<h2>Ressourcen<\/h2>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-161652966 > .col-inner {\n  padding: 50px 0px 0px 0px;\n  margin: 30px 0px 0px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-643029677\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n  \n    <div class=\"row eneko-case-studies radius-30 large-columns-3 medium-columns-2 small-columns-1 slider row-slider slider-nav-simple slider-nav-outside slider-nav-push\"  data-flickity-options='{&quot;imagesLoaded&quot;: true, &quot;groupCells&quot;: &quot;100%&quot;, &quot;dragThreshold&quot; : 5, &quot;cellAlign&quot;: &quot;left&quot;,&quot;wrapAround&quot;: true,&quot;prevNextButtons&quot;: true,&quot;percentPosition&quot;: true,&quot;pageDots&quot;: true, &quot;rightToLeft&quot;: false, &quot;autoPlay&quot; : false}' >\n\n  <div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/us-government-shutdown-life-sciences-impact\/\" class=\"plain\" aria-label=\"Umgang mit einem m\u00f6glichen Shutdown der US-Regierung: Implizit\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector.jpg\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"Umgang mit den potenziellen Auswirkungen eines US-Regierungsstillstands auf den Life-Sciences-Sektor\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector.jpg 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector-330x248.jpg 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/navigating-potential-us-government-shutdown-implications-life-sciences-sector-16x12.jpg 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">11. M\u00e4rz 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/de\/category\/blogs\/\">Blogs<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/us-government-shutdown-life-sciences-impact\/\" class=\"plain\">Umgang mit einem m\u00f6glichen Shutdown der US-Regierung: Implizit\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tW\u00e4hrend die Gesetzgeber in Washington, D.C., vor einer kritischen Frist am 14. M\u00e4rz stehen, um die Bundesausgaben abzuschlie\u00dfen, besteht die M\u00f6glichkeit einer Schlie\u00dfung der US-Regierung \u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/us-government-shutdown-life-sciences-impact\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/blogs\/\" class=\"category-blogs\">Blogs<\/a> <a href=\"https:\/\/regask.com\/de\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Vereinigte Staaten<\/a> <a href=\"https:\/\/regask.com\/de\/category\/blogs\/pharma-and-biotech-news\/\" class=\"category-pharma-and-biotech-news\">Pharma &amp; Biotech<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/2024-gartner-feature\/\" class=\"plain\" aria-label=\"RegASK im Gartner Market Guide f\u00fcr Regulierungen aufgef\u00fchrt \u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner.jpg\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"Regask Anerkannter Marktf\u00fchrer Gartner\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner.jpg 800w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner-330x248.jpg 330w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/regask-recognized-market-guide-gartner-16x12.jpg 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">21. November 2024 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/de\/category\/company-news\/\">Unternehmens-Neuigkeiten<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/2024-gartner-feature\/\" class=\"plain\">RegASK im Gartner Market Guide f\u00fcr Regulierungen aufgef\u00fchrt \u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tWir freuen uns, Ihnen mitteilen zu k\u00f6nnen, dass RegASK in Gartners Market Guide f\u00fcr Regulatory Intelligence Solutions aufgenommen wurde! Diese Anerkennung \u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/2024-gartner-feature\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/company-news\/\" class=\"category-company-news\">Unternehmens-Neuigkeiten<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/the-2025-state-of-regulatory-affairs-and-compliance-report\/\" class=\"plain\" aria-label=\"Der Bericht zum Stand der Regulierungs- und Compliance-Angelegenheiten im Jahr 2025 \u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"800 600 Website Ausgew\u00e4hltes Bild\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/2025-survey-report-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">15. November 2024 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/de\/category\/reports\/\">Berichte<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/the-2025-state-of-regulatory-affairs-and-compliance-report\/\" class=\"plain\">Der Bericht zum Stand der Regulierungs- und Compliance-Angelegenheiten im Jahr 2025 \u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tIst Ihr Unternehmen auf die regulatorischen Herausforderungen des Jahres 2025 vorbereitet? Die regulatorische Landschaft im Jahr 2025 ist komplexer denn je, mit neuen Fortschritten\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/the-2025-state-of-regulatory-affairs-and-compliance-report\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/reports\/\" class=\"category-reports\">Berichte<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/doge-fda-lease-cancellations\/\" class=\"plain\" aria-label=\"DOGE behauptet, $30M Einsparungen durch die K\u00fcndigung von 30 FDA-Leasingvertr\u00e4gen zu erzielen\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"Doge behauptet, 30 Millionen Dollar durch K\u00fcndigung von 30 FDA-Pachtvertr\u00e4gen gespart zu haben\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/doge-claims-30m-savings-canceling-30-fda-leases-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">7. M\u00e4rz 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/de\/category\/news\/\">Regulatorische Neuigkeiten<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/doge-fda-lease-cancellations\/\" class=\"plain\">DOGE behauptet, $30M Einsparungen durch die K\u00fcndigung von 30 FDA-Leasingvertr\u00e4gen zu erzielen<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/doge-fda-lease-cancellations\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Vereinigte Staaten<\/a> <a href=\"https:\/\/regask.com\/de\/category\/news\/\" class=\"category-news\">Regulatorische Neuigkeiten<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/france-ansm-ce-mark-exemption\/\" class=\"plain\" aria-label=\"ANSM (Frankreich) kl\u00e4rt das Verfahren zur Befreiung von der CE-Kennzeichnung f\u00fcr M\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"Ansm France kl\u00e4rt den Prozess zur Befreiung von der CE-Kennzeichnung f\u00fcr Medizinprodukte\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/02\/ansm-france-clarifies-ce-mark-exemption-process-medical-devices-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">26. Februar 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/de\/category\/news\/\">Regulatorische Neuigkeiten<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/france-ansm-ce-mark-exemption\/\" class=\"plain\">ANSM (Frankreich) kl\u00e4rt das Verfahren zur Befreiung von der CE-Kennzeichnung f\u00fcr M\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tAm 27. Januar 2025 ver\u00f6ffentlichte die Nationale Sicherheitsagentur f\u00fcr Arzneimittel und Gesundheitsprodukte (ANSM) in Frankreich ein wichtiges Update zum Prozess \u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/france-ansm-ce-mark-exemption\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/region\/europe\/france-regulations\/\" class=\"category-france-regulations\">Frankreich<\/a> <a href=\"https:\/\/regask.com\/de\/category\/news\/medical-devices-insights\/\" class=\"category-medical-devices-insights\">Medizinische Ger\u00e4te<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/us-fda-ai-drug-regulation-guidance\/\" class=\"plain\" aria-label=\"US-amerikanische FDA gibt Leitlinienentwurf zum Einsatz von KI in regulatorischen\u2026 bekannt\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"US-amerikanische FDA k\u00fcndigt Leitlinienentwurf zur Nutzung k\u00fcnstlicher Intelligenz f\u00fcr regulatorische Entscheidungen bei Arzneimitteln und biologischen Produkten an\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-draft-guidance-ai-use-regulatory-decision-making-drug-biological-products-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">22. Januar 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/de\/category\/news\/\">Regulatorische Neuigkeiten<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/us-fda-ai-drug-regulation-guidance\/\" class=\"plain\">US-amerikanische FDA gibt Leitlinienentwurf zum Einsatz von KI in regulatorischen\u2026 bekannt<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tAm 6. Januar 2025 gab die US-amerikanische Food and Drug Administration (FDA) die Ver\u00f6ffentlichung eines Leitlinienentwurfs mit dem Titel \u201e\u00dcberlegungen f\u00fcr die USA\u2026\u201c bekannt. <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/us-fda-ai-drug-regulation-guidance\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Vereinigte Staaten<\/a> <a href=\"https:\/\/regask.com\/de\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Pharma und Biotech<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/us-fda-pediatric-drug-meeting\/\" class=\"plain\" aria-label=\"US-amerikanische FDA k\u00fcndigt \u00f6ffentliche Sitzung zur Gesetzgebung f\u00fcr Kinderarzneimittel an \u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"US-amerikanische FDA k\u00fcndigt \u00f6ffentliche Sitzung an: P\u00e4diatrische Gesetzgebung beeinflusst Entwicklung biologischer Arzneimittel bei Kindern\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/us-fda-announces-public-meeting-paediatric-legislation-impact-drug-biologic-development-children-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">8. Januar 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/de\/category\/news\/\">Regulatorische Neuigkeiten<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/us-fda-pediatric-drug-meeting\/\" class=\"plain\">US-amerikanische FDA k\u00fcndigt \u00f6ffentliche Sitzung zur Gesetzgebung f\u00fcr Kinderarzneimittel an \u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tDie Food and Drug Administration (FDA) hat eine \u00f6ffentliche Sitzung mit dem Titel \u201eTreffen interessierter Parteien: Umsetzung der besten Pharm\u2026\u201c anberaumt. <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/us-fda-pediatric-drug-meeting\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Vereinigte Staaten<\/a> <a href=\"https:\/\/regask.com\/de\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Pharma und Biotech<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/us-fda-real-world-evidence-center\/\" class=\"plain\" aria-label=\"FDA (USA) richtet neues Zentrum f\u00fcr Real-World Evidence ein \u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"FDA USA gr\u00fcndet neues Zentrum f\u00fcr Real World Evidence Innovation zur Verbesserung der Arzneimittelsicherheit und Wirksamkeits\u00fcberwachung\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-establishes-new-center-real-world-evidence-innovation-enhance-drug-safety-efficacy-monitoring-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">20. Dezember 2024 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/de\/category\/news\/\">Regulatorische Neuigkeiten<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/us-fda-real-world-evidence-center\/\" class=\"plain\">FDA (USA) richtet neues Zentrum f\u00fcr Real-World Evidence ein \u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tAm 12. Dezember 2024 gab die US-amerikanische Food and Drug Administration (FDA) die Gr\u00fcndung des Center for Real-World Evidence and Innovatio\u2026 bekannt. <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/us-fda-real-world-evidence-center\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Vereinigte Staaten<\/a> <a href=\"https:\/\/regask.com\/de\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Pharma und Biotech<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-normal box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" >\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:56%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/portuguese-industry-us-alcohol-labels\/\" class=\"plain\" aria-label=\"Portugiesische Industrie lehnt US-Vorschlag f\u00fcr Krebsbek\u00e4mpfung ab\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels.png\" class=\"attachment-medium_large size-medium_large wp-post-image\" alt=\"Portugiesische Industrie widersetzt sich US-Vorschlag Krebswarnungen Alkoholetiketten\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels.png 800w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/01\/portuguese-industry-opposes-us-proposal-cancer-warnings-alcohol-labels-16x12.png 16w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" style=\"padding:20px 0px 0px 0px;\">\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"post-meta is-small op-8\">28. Januar 2025 -  <a style=\"color:#453AAB!important;\" href=\"https:\/\/regask.com\/de\/category\/news\/\">Regulatorische Neuigkeiten<\/a><\/div>\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-large\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/portuguese-industry-us-alcohol-labels\/\" class=\"plain\">Portugiesische Industrie lehnt US-Vorschlag f\u00fcr Krebsbek\u00e4mpfung ab<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tDie US-Gesundheitsbeh\u00f6rde erw\u00e4gt die Einf\u00fchrung obligatorischer Warnhinweise zu Krebs auf alkoholischen Getr\u00e4nken, eine \u00e4hnliche Ma\u00dfnahme \u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/portuguese-industry-us-alcohol-labels\/\" class=\"button  is-link is-small mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/news\/pharma-biotech-latest-insights\/\" class=\"category-pharma-biotech-latest-insights\">Pharma und Biotech<\/a> <a href=\"https:\/\/regask.com\/de\/category\/region\/europe\/portugal-regulations\/\" class=\"category-portugal-regulations\">Portugal<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><\/div>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-643029677 > .col-inner {\n  margin: 0px 0px 80px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n\t\t<\/div>\n\n\t\t\n<style>\n#section_113422710 {\n  padding-top: 0px;\n  padding-bottom: 0px;\n}\n<\/style>\n\t<\/section>","protected":false},"excerpt":{"rendered":"","protected":false},"author":32,"featured_media":8083,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-transparent-header.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-8247","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>RAPS Euro Convergence 2025 | RegASK<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/de\/rappt-euro-konvergenz-2025\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RAPS Euro Convergence 2025\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/de\/rappt-euro-konvergenz-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-05T02:15:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS.png\" \/>\n\t<meta property=\"og:image:width\" content=\"720\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/raps-euro-convergence-2025\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/raps-euro-convergence-2025\\\/\",\"name\":\"RAPS Euro Convergence 2025 | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/raps-euro-convergence-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/raps-euro-convergence-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/RegASK-RAPS.png\",\"datePublished\":\"2025-05-02T09:49:32+00:00\",\"dateModified\":\"2025-05-05T02:15:36+00:00\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/raps-euro-convergence-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/raps-euro-convergence-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/RegASK-RAPS.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/RegASK-RAPS.png\",\"width\":720,\"height\":720,\"caption\":\"Regask Raps\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"RAPS Euro-Konvergenz 2025 |","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/de\/rappt-euro-konvergenz-2025\/","og_locale":"de_DE","og_type":"article","og_title":"RAPS Euro Convergence 2025","og_url":"https:\/\/regask.com\/de\/rappt-euro-konvergenz-2025\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_modified_time":"2025-05-05T02:15:36+00:00","og_image":[{"width":720,"height":720,"url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@ASKRegASK","twitter_misc":{"Est. reading time":"5\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/regask.com\/raps-euro-convergence-2025\/","url":"https:\/\/regask.com\/raps-euro-convergence-2025\/","name":"RAPS Euro-Konvergenz 2025 |","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/raps-euro-convergence-2025\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/raps-euro-convergence-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS.png","datePublished":"2025-05-02T09:49:32+00:00","dateModified":"2025-05-05T02:15:36+00:00","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/raps-euro-convergence-2025\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/raps-euro-convergence-2025\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/03\/RegASK-RAPS.png","width":720,"height":720,"caption":"Regask Raps"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Intelligentere Regulierungsentscheidungen erm\u00f6glichen","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd"]}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/pages\/8247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/comments?post=8247"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/pages\/8247\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media\/8083"}],"wp:attachment":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media?parent=8247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}